ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2287

Serum Urate and Its Association with Endothelial Dysfunction in Young Adults

Michael B. Saddekni1, Kenneth G. Saag1, Tanja Dudenbostel2, Suzanne Oparil2, David A. Calhoun2, Daniel I. Feig3, Paul M. Muntner4, David T. Redden5, Phillip J. Foster1, Elizabeth J. Rahn1, Stephanie R. Biggers1, Peng Li5 and Angelo L. Gaffo1, 1Department of Medicine, Division of Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Department of Medicine, Division of Cardiovascular Disease, University of Alabama at Birmingham, Birmingham, AL, 3Department of Pediatrics, University of Alabama at Birmingham, Birmingham, AL, 4Department of Epidemiology, University of Alabama at Birmingham, Birmingham, AL, 5Department of Biostatistics, University of Alabama at Birmingham, Birmingham, AL

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: endothelial cells, Ethnic studies, hypertension, hyperuricemia and young adults

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 15, 2016

Title: Metabolic and Crystal Arthropathies - Poster II: Epidemiology and Mechanisms of Disease

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Both serum urate (sUA) and endothelial dysfunction have been associated with hypertension and cardiovascular disease. Increasing sUA level has been associated with endothelial dysfunction and higher inflammatory markers (e.g., high sensitivity c –reactive protein [hsCRP]). To date, however, few studies have examined the relationship between sUA, endothelial dysfunction, and blood pressure (BP) including young and largely healthy individuals. Objectives: To determine whether there is an association between higher sUA, endothelial dysfunction as measured by flow-mediated dilation (FMD), and BP in young adults.

Methods: We conducted a cross-sectional analysis of baseline data for consecutively enrolled individuals (age 18 – 40 years). Inclusion criteria were: baseline systolic BP (SBP) ≥ 120 and <160 mmHg or diastolic BP (DBP) ≥ 80 and < 100 mmHg, and sUA ≥ 5.0 mg/dL for men or ≥ 4.0 mg/dL for women. Clinic SBP and DBP, 24- hours ambulatory BP monitoring (ABPM), hsCRP, and sUA level were obtained. Associations between sUA, endothelial dysfunction measured by FMD, and ABPM variables were evaluated using a general linear model.  Adjustments for age, gender, race, and BMI were applied after significant univariate results. Data reported are mean +standard deviation (SD).

Results: There were 69 participants included in the analysis. Participants recruited had a mean age of 29.0 ± 6.9 years, 30 % were female, 43 % African-Americans, mean BMI was 29.0 ± 6.0 kg/m², and mean sUA was 5.9 ± 1.1 mg/dL (range from 3.9 to 8.5 mg/dL). We found no significant cross-sectional associations between sUA, FMD, and BP variables assessed by ABPM (Table). Participants in the upper tertile of sUA had significantly more endothelial dysfunction as measured by FMD than those in the lower tertiles (Figure). However, this difference was no longer significant after multivariable adjustment age, gender, race, and BMI.

Conclusion: In this cross-sectional analysis of young adults, there was no evidence to support an association between sUA levels and endothelial dysfunction or BP.  Endothelial dysfunction or BP might be associated with changes in sUA when measured longitudinally in individuals, but not when measured cross-sectionally in populations. Larger studies will be needed to confirm these results. Table. Cross-sectional correlation between sUA, FMD, and Ambulatory Blood Pressure parameters

Parameters    r p-value
sUA and FMD -0.19 0.15
sUA and SBP -0.02 0.85
sUA and DBP -0.07 0.61
sUA and MAP -0.02 0.86

sUA: serum uric acid, SBP: systolic blood pressure, DBP: diastolic blood pressure, MAP: mean arterial blood pressure, FMD: flow-mediated dilation                                         Figure. Tertiles of sUA and FMD unadjusted correlation  

The p for trend for FMD across SUA tertiles is p = 0.006


Disclosure: M. B. Saddekni, None; K. G. Saag, Ardea/AstraZeneca, 5,Crealta, 5,Takeda, 5,Ardea/AstraZeneca, 2,Crealta, 2,Takeda, 2; T. Dudenbostel, None; S. Oparil, Actelion Pharmaceuticals US, 2,AstraZeneca, 2,Bayer Healthcare Pharmaceuticals, 2,Merck and Co., 2,NIH/NHLBI, 2,NHLBI, 2,Novartis Pharmaceutical Corporation, 2,Amgen, 5,AstraZeneca, 5,Bayer, 5,Boehringer Ingelheim, 5,Forest Labs Inc., 5,GlaxoSmithKline, 5,Medtronic, 5; D. A. Calhoun, None; D. I. Feig, None; P. M. Muntner, None; D. T. Redden, None; P. J. Foster, None; E. J. Rahn, None; S. R. Biggers, None; P. Li, None; A. L. Gaffo, US Government, 3,Cymabay, 5,Ardea, 5,Amgen, 2,AstraZeneca, 2.

To cite this abstract in AMA style:

Saddekni MB, Saag KG, Dudenbostel T, Oparil S, Calhoun DA, Feig DI, Muntner PM, Redden DT, Foster PJ, Rahn EJ, Biggers SR, Li P, Gaffo AL. Serum Urate and Its Association with Endothelial Dysfunction in Young Adults [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/serum-urate-and-its-association-with-endothelial-dysfunction-in-young-adults/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/serum-urate-and-its-association-with-endothelial-dysfunction-in-young-adults/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology